Allena pharmaceuticals, inc. (ALNA)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17
Cash flows from operating activities:
Net loss

-7,585

-11,359

-13,288

-11,273

-11,419

-9,611

-9,510

-8,647

-7,880

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-5,671

Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense

1,035

778

810

772

629

537

595

513

404

222

99

100

96

Depreciation expense

41

42

42

39

40

34

17

8

19

20

19

17

17

Non-cash interest expense

2

2

2

2

2

2

2

82

75

87

101

76

87

Amortization of operating lease assets

128

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash lease expense

6

-

-

-

125

-

-

-

-

-

-

-

-

Amortization of premium on investments

-

-

-

-

-

-

-

-

-

0

0

5

28

Change in fair value of warrant liability

-

-

-

-

-

-

-

-

-

64

161

35

-3

Changes in assets and liabilities:
Prepaid expenses and other current assets

-712

868

-1,566

2,410

-1,510

648

1,267

-16

-612

962

227

-136

-69

Other assets

-

0

0

-267

144

-68

95

-35

42

-

-

-

-

Accounts payable

-1,309

-562

1,318

-318

534

442

725

-1,255

529

49

340

-94

-96

Accrued expenses

-1,498

-

-

-

-962

-

-

-

-

-

-

-

-

Accrued expenses

-

-

-

-

-

-

-

604

-616

-

632

60

-824

Operating lease liabilities

-90

-163

-124

-119

-125

-

-

-

-

-

-

-

-

Other liabilities

-

-

-

-

-

2

11

4

3

-

-

-

-

Net cash used in operating activities

-8,558

-11,925

-9,071

-12,826

-9,810

-8,710

-8,210

-8,023

-6,896

-

-

-

-

Cash flows from investing activities:
Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-6,297

Purchases of property and equipment

-

0

21

17

84

162

41

84

31

1

0

5

51

Maturities of investments

-

-

-

-

-

-

-

-

-

0

3,249

12,122

9,350

Net cash (used in) provided by investing activities

-

-

-

-

-

-

-

-

-

-

-

-

9,299

Net cash used in investing activities

-

0

-21

-17

-84

-162

-41

-84

-31

-

-

-

-

Proceeds from exercise of stock options

10

17

6

0

13

52

6

80

1

23

3

0

2

Repayment of loan payable

1,000

-

-

-

-

0

0

9,492

1,000

-

-

-

-

Payments of common stock offering costs

-

-

-

-

-

-

-

-

186

-

-

-

-

Other

-8

-7

-8

-7

-7

-

-

-

-

-

-

-

-

Net cash (used in) provided by financing activities

-998

2,513

-12

9,611

6

-44

-43

578

-1,185

-

-

-

-

Net decrease in cash and cash equivalents

-9,556

-9,412

-9,104

-3,232

-9,888

-8,916

-8,294

-7,529

-8,112

-

-

-

-

Supplemental disclosures:
Net cash (used in) provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

2

Net (decrease) increase in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

3,004

Right-of-use assets obtained in exchange of operating lease obligations

-

0

0

0

992

-

-

-

-

-

-

-

-

Accretion of convertible preferred stock to redemption value

-

-

-

-

-

-

-

-

-

6

18

17

17